Ardent Health (ARDT) Stock: Buy, Sell, or Hold?
ARDT - Ardent Health, Inc.
$12.06
-0.06 (-0.50%)
▼
5d:
+0.92%
30d:
+10.14%
90d:
+15.74%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 04, 2026
12d
Get Alerted When ARDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ARDT shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ARDT shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.10
Based on 9.7% avg growth
INTRINSIC VALUE TODAY
$9.38
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDT is currently trading at $12.06, which is considered extended relative to its 30-day fair value range of $10.41 to $11.63. From a valuation perspective, the stock is trading at a premium (Forward PE: 9.6) compared to its historical average (7.6). At these levels, the market is pricing in 8.1% annual earnings growth.
Technical Outlook: Technically, ARDT is in a uptrend. Immediate support is located at $10.71, while resistance sits at $12.46.
Market Sentiment: ARDT scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARDT is in a uptrend. Immediate support is located at $10.71, while resistance sits at $12.46.
Market Sentiment: ARDT scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.41 -
$11.63
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
27.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($12.67)
- BULLISH: Expecting earnings turnaround to 8.1% growth with -1.4% revenue growth
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.41 -
$11.63
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$10.71
Resistance Level
$12.47
Current Trend
Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.61
Wall Street Target
$12.67
(+5.0%)
Revenue Growth (YoY)
-1.4%
Earnings Growth (YoY)
-77.1%
Profit Margin
1.2%
Valuation Premium vs History
+8.1% premium
PE vs Historical
9.6 vs 7.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.1%
(market-implied from PE analysis)
1-Year Target
$13.04
(+8%)
2-Year Target
$14.09
(+17%)
3-Year Target
$15.23
(+26%)
3-Yr Target (if PE normalizes)
(PE: 10→8)
PE COMPRESSION
$12.05
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 15.4%)
$38.31
(+218%)
Base:
(SPY PE: 9.6, Growth: 15.4%)
$18.53
(+54%)
Bear:
(PE: 7.6, Growth: 15.4%)
$14.66
(+22%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 22.44 | Current EPS (TTM): $0.54
Bull Case
$26.66
(+121%)
Analyst growth 100.0%, PE expands to 24.7
Base Case
$24.24
(+101%)
Market implied 100.0%, PE stable at 22.4
Bear Case
$8.24
(-32%)
Severe decline -20.0%, PE contracts to 19.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 7:37 AM ET
Data refreshes hourly during market hours. Next update: 8:37 AM
Data refreshes hourly during market hours. Next update: 8:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$286 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 60 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 42 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 59 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
14 analysts |
$134 | 56 HOLD |
